Mediwound Gross Profit Margin vs Pretax Profit Margin Analysis
| MDWD Stock | USD 16.90 0.43 2.48% |
Mediwound financial indicator trend analysis is infinitely more than just investigating Mediwound recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mediwound is a good investment. Please check the relationship between Mediwound Gross Profit Margin and its Pretax Profit Margin accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.
Gross Profit Margin vs Pretax Profit Margin
Gross Profit Margin vs Pretax Profit Margin Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mediwound Gross Profit Margin account and Pretax Profit Margin. At this time, the significance of the direction appears to have totally related.
The correlation between Mediwound's Gross Profit Margin and Pretax Profit Margin is 1.0. Overlapping area represents the amount of variation of Gross Profit Margin that can explain the historical movement of Pretax Profit Margin in the same time period over historical financial statements of Mediwound, assuming nothing else is changed. The correlation between historical values of Mediwound's Gross Profit Margin and Pretax Profit Margin is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit Margin of Mediwound are associated (or correlated) with its Pretax Profit Margin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Pretax Profit Margin has no effect on the direction of Gross Profit Margin i.e., Mediwound's Gross Profit Margin and Pretax Profit Margin go up and down completely randomly.
Correlation Coefficient | 1.0 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Gross Profit Margin
Pretax Profit Margin
Most indicators from Mediwound's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mediwound current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.At present, Mediwound's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 145.1 M, whereas Issuance Of Capital Stock is forecasted to decline to about 21.9 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 903K | 8.9M | 427K | 405.7K | Depreciation And Amortization | 1.2M | 1.3M | 1.3M | 810.5K |
Mediwound fundamental ratios Correlations
Click cells to compare fundamentals
Mediwound Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mediwound fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Common Stock Shares Outstanding | 3.9M | 3.9M | 3.9M | 5.0M | 9.0M | 9.5M | |
| Total Assets | 40.6M | 31.1M | 19.7M | 50.0M | 66.5M | 44.6M | |
| Other Current Liab | 569K | 4.8M | 5.5M | 6.3M | 5.3M | 3.6M | |
| Total Current Liabilities | 10.4M | 8.3M | 10.7M | 12.1M | 10.8M | 7.6M | |
| Total Stockholder Equity | 15.2M | 7.3M | (4.6M) | 10.9M | 31.6M | 33.2M | |
| Other Liab | 13.0M | 13.8M | 12.2M | 26.2M | 23.6M | 15.9M | |
| Property Plant And Equipment Net | 4.5M | 4.5M | 4.0M | 3.6M | 15.9M | 16.7M | |
| Net Debt | (5.2M) | (15.6M) | (9.7M) | (33.0M) | (5.5M) | (5.8M) | |
| Retained Earnings | (125.8M) | (135.0M) | (148.5M) | (168.1M) | (174.8M) | (183.6M) | |
| Accounts Payable | 4.1M | 3.0M | 4.7M | 5.7M | 5.5M | 3.2M | |
| Cash | 7.2M | 17.4M | 11.0M | 33.9M | 11.9M | 20.9M | |
| Non Current Assets Total | 5.0M | 4.9M | 4.8M | 4.2M | 16.8M | 17.6M | |
| Non Currrent Assets Other | 6K | (4.9M) | (4.3M) | (3.8M) | 183K | 306.7K | |
| Other Assets | 48K | 6K | 469K | 364K | 327.6K | 311.2K | |
| Cash And Short Term Investments | 29.5M | 21.6M | 11.0M | 33.9M | 41.5M | 31.9M | |
| Net Receivables | 4.6M | 2.8M | 2.3M | 9.3M | 4.4M | 4.2M | |
| Liabilities And Stockholders Equity | 40.6M | 31.1M | 19.7M | 50.0M | 66.5M | 44.6M | |
| Non Current Liabilities Total | 15.0M | 15.5M | 13.6M | 27.0M | 24.0M | 17.0M | |
| Inventory | 1.6M | 1.4M | 1.2M | 2.0M | 2.8M | 1.7M | |
| Other Current Assets | 216K | 646K | 439K | 650K | 889K | 844.6K | |
| Other Stockholder Equity | 140.9M | 142.2M | 143.9M | 178.9M | 206.3M | 137.7M | |
| Total Liab | 25.4M | 23.8M | 24.3M | 39.1M | 34.9M | 31.0M | |
| Property Plant And Equipment Gross | 4.5M | 4.5M | 4.0M | 3.6M | 23.1M | 24.2M | |
| Total Current Assets | 35.6M | 26.2M | 15.0M | 45.8M | 49.7M | 38.0M | |
| Accumulated Other Comprehensive Income | (25K) | (17K) | (40K) | (19K) | (5K) | (18.9K) | |
| Intangible Assets | 429K | 363K | 297K | 231K | 165K | 156.8K | |
| Property Plant Equipment | 4.5M | 4.5M | 4.0M | 3.6M | 4.1M | 2.6M | |
| Net Tangible Assets | 14.7M | 6.9M | (4.9M) | 10.7M | 9.6M | 7.6M | |
| Short Term Investments | 0.0 | 16.9M | 22.0M | 4.0M | 29.7M | 31.2M | |
| Current Deferred Revenue | 249K | 462K | 543K | 63K | 24K | 22.8K | |
| Non Current Liabilities Other | 11.7M | 12.3M | 11.8M | 10.2M | 9.9M | 11.3M | |
| Net Invested Capital | 15.2M | 7.3M | (4.6M) | 10.9M | 31.6M | 33.2M | |
| Net Working Capital | 25.2M | 17.9M | 4.2M | 33.8M | 38.9M | 21.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Revenue Per Share 2.18 | Quarterly Revenue Growth 0.061 | Return On Assets (0.16) | Return On Equity (0.76) |
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.